Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 16, 2008New England Journal of MedicineOpen Access

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJoseph A. SparanoTisch Cancer InstituteMWMolin WangBrigham and Women's HospitalSMSilvana MartinoUniversity of Vermont

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sparano et al. (2008) studied this question.

synapsesocial.com/papers/6a022d3f00c19b66c6780edahttps://doi.org/10.1056/nejmoa0707056
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HER2 and Response to Paclitaxel in Node-Positive Breast Cancer2007 · 605 citations
  2. 2Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer2006 · 730 citations
  3. 3Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer2005 · 552 citations